Vera Therapeutics, Inc.
VERA
36 insider filings · Latest: Sep 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2024 | Sep 18 8:38 PM | BETH C SEIDENBERG | Proposed Sale | 15,000 | $40.02 | $600.3K | — | View → |
| Sep 18, 2024 | Sep 18 8:38 PM | SAMUEL B SEIDENBERG IRREV TRUST U/A DTD 07/01/2013 | Proposed Sale | 1,476 | $40.02 | $59.1K | — | View → |
| Sep 11, 2024 | Sep 11 8:19 PM | MARSHALL FORDYCE | Proposed Sale | 31,250 | $37.55 | $1.2M | — | View → |
| Aug 28, 2024 | Aug 28 8:15 PM | MARSHALL FORDYCE | Proposed Sale | 30,320 | $37.65 | $1.1M | — | View → |
← Previous
Page 3 of 3
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | Feb 7 1:00 AM | Sean GrantCHIEF FINANCIAL OFFICER | Grant/Award | 50,000 | $42.74 | 50,000(D) | View → |
| Feb 4, 2026 | Feb 7 1:00 AM | Laurence Matthew SkeltonChief Commercial Officer | Grant/Award | 40,000 | $42.74 | 40,000(D) | View → |
| Feb 4, 2026 | Feb 7 1:00 AM | William D. TurnerChief Regulatory Officer | Grant/Award | 50,000 | $42.74 | 50,000(D) | View → |
| Feb 4, 2026 | Feb 7 1:00 AM | David Lee JohnsonChief Operating Officer | Grant/Award | 40,000 | $42.74 | 40,000(D) | View → |
| Feb 4, 2026 | Feb 7 1:00 AM | Robert BrennerChief Medical Officer | Grant/Award | 50,000 | $42.74 | 50,000(D) | View → |
← Previous
Page 2 of 2